SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001354488-16-007881
Filing Date
2016-06-23
Accepted
2016-06-23 11:09:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D cbmg_sc13d.htm SC 13D 56512
  Complete submission text file 0001354488-16-007881.txt   58183
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Subject) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82437 | Film No.: 161728030
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 369 LUMO ROAD HONGSHAN DISTRICT WUHAN, HUBEI F4 430070
Business Address 369 LUMO ROAD HONGSHAN DISTRICT WUHAN, HUBEI F4 430070 86-027-87596552
Dangdal International Group Co. Ltd (Filed by) CIK: 0001678024 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13D